Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 4/20 | 0.62 |
| ▸ | CCKAR | P32238 | 1/20 | 0.62 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.62 |
| ▸ | GLP1R | P43220 | 9/20 | 0.61 |
| ▸ | ECE1 | P42892 | 1/20 | 0.61 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.61 |
| ▸ | IL23R | Q5VWK5 | 6/20 | 0.60 |
| ▸ | PTH1R | Q03431 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30974043 | 0.89 | IL23R (0.66) | GLP1RECE1MUS81IL23R | |
| SCHEMBL29683668 | 0.89 | GLP1R (0.65) | CCKBRGLP1RECE1MUS81IL23R | |
| SCHEMBL29365074 | 0.89 | GLP1R (0.65) | CCKBRGLP1RECE1MUS81IL23R | |
| SCHEMBL30372047 | 0.89 | KISS1R (0.58) | CCKBRCCKAROPRD1IL23R | |
| SCHEMBL29695434 | 0.89 | IL23R (0.67) | GLP1RECE1MUS81IL23RPTH1R | |
| SCHEMBL29982283 | 0.89 | KISS1R (0.62) | IL23R | |
| SCHEMBL30401709 | 0.89 | KISS1R (0.62) | IL23R | |
| SCHEMBL31378965 | 0.88 | GLP1R (0.71) | GLP1RECE1MUS81IL23R | |
| SCHEMBL29416056 | 0.88 | KISS1R (0.62) | GLP1RECE1MUS81PTH1R | |
| SCHEMBL30974278 | 0.88 | IL23R (0.62) | CCKBRCCKAROPRD1GLP1RECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12596073-B2 | Nanoscale optical biosensor based on material-associated single walled carbon nanotubes | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) | 2026-04-07 | — | — | US | disclosed |
| US-20240019374-A1 | A NANOSCALE OPTICAL BIOSENSOR BASED ON MATERIAL-ASSOCIATED SINGLE WALLED CARBON NANOTUBES | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) | 2024-01-18 | — | — | US | disclosed |
| EP-4158319-A1 | A NANOSCALE OPTICAL BIOSENSOR BASED ON MATERIAL-ASSOCIATED SINGLE WALLED CARBON NANOTUBES | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2023-04-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12596073-B2 | Nanoscale optical biosensor based on material-associated single walled carbon nanotubes | VCL, VDAC1, TRPV6 | CCKBR 248/4885CCKAR 224/4885OPRD1 496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.